Mark A Popovsky - Net Worth and Insider Trading

Mark A Popovsky Net Worth

The estimated net worth of Mark A Popovsky is at least $616,462 dollars as of 2025-05-01. Mark A Popovsky is the VP, Corporate Medical Director of Haemonetics Corp and owns about 9,782 shares of Haemonetics Corp (HAE) stock worth over $616,462. Details can be seen in Mark A Popovsky's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark A Popovsky has not made any transactions after 2008-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Mark A Popovsky

To

Mark A Popovsky Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark A Popovsky owns 1 companies in total, including Haemonetics Corp (HAE) .

Click here to see the complete history of Mark A Popovsky’s form 4 insider trades.

Insider Ownership Summary of Mark A Popovsky

Ticker Company Transaction Date Type of Owner
HAE Haemonetics Corp 2008-05-01 Vp & Corporate Medical Director

Mark A Popovsky Latest Holdings Summary

Mark A Popovsky currently owns a total of 1 stock. Mark A Popovsky owns 9,782 shares of Haemonetics Corp (HAE) as of May 1, 2008, with a value of $616,462.

Latest Holdings of Mark A Popovsky

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HAE Haemonetics Corp 2008-05-01 9,782 63.02 616,462

Holding Weightings of Mark A Popovsky


Mark A Popovsky Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark A Popovsky has made a total of 0 transactions in Haemonetics Corp (HAE) over the past 5 years. The most-recent trade in Haemonetics Corp is the acquisition of 492 shares on May 1, 2008, which cost Mark A Popovsky around $10,910.

Insider Trading History of Mark A Popovsky

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark A Popovsky Trading Performance

GuruFocus tracks the stock performance after each of Mark A Popovsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark A Popovsky is 1.88%. GuruFocus also compares Mark A Popovsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark A Popovsky within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark A Popovsky's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark A Popovsky

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.31 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -0.44 LIMIT LIMIT LIMIT LIMIT LIMIT

Mark A Popovsky Ownership Network

Ownership Network List of Mark A Popovsky

No Data

Ownership Network Relation of Mark A Popovsky

Insider Network Chart

Mark A Popovsky Owned Company Details

What does Haemonetics Corp do?

Who are the key executives at Haemonetics Corp?

Mark A Popovsky is the Vp & Corporate Medical Director of Haemonetics Corp. Other key executives at Haemonetics Corp include President & Global Hospital Stewart W Strong , EVP & Chief Technology Officer Anila Lingamneni , and EVP and General Counsel Michelle L Basil .

Haemonetics Corp (HAE) Insider Trades Summary

Over the past 18 months, Mark A Popovsky made no insider transaction in Haemonetics Corp (HAE). Other recent insider transactions involving Haemonetics Corp (HAE) include a net sale of 14,588 shares made by Stewart W Strong , a net sale of 16,652 shares made by Michelle L Basil , and a net sale of 4,520 shares made by Anila Lingamneni .

In summary, during the past 3 months, insiders sold 0 shares of Haemonetics Corp (HAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 38,339 shares of Haemonetics Corp (HAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 38,339 shares.

Haemonetics Corp (HAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Haemonetics Corp Insider Transactions

No Available Data

Mark A Popovsky Mailing Address

Above is the net worth, insider trading, and ownership report for Mark A Popovsky. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark A Popovsky's mailing address is: Braintree Ma 02184.